We are live on ! Find out more
QTTB icon

Q32 Bio

83 hedge funds and large institutions have $38.4M invested in Q32 Bio in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 27 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

443% more call options, than puts

Call options by funds: $114K | Put options by funds: $21K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.13% less ownership

Funds ownership: 2.45%2.32% (-0.13%)

5% less funds holding

Funds holding: 8783 (-4)

23% less capital invested

Capital invested by funds: $49.9M → $38.4M (-$11.5M)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

44% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 27

Holders
83
Holders Change
-4
Holders Change %
-4.6%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
15
Reduced
27
Closed
14
Calls
$114K
Puts
$21K
Net Calls
+$93K
Net Calls Change
+$1.16M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
51
Bank of New York Mellon
New York
$31K
RJA
52
Raymond James & Associates
Florida
$27K
DCM
53
Dimension Capital Management
Florida
$26K
HSBC Holdings
54
HSBC Holdings
United Kingdom
$25K -$3.87K -95 -10%
Simplex Trading
55
Simplex Trading
Illinois
$24K -$45.9K -1,126 -57%
LP
56
LMR Partners
United Kingdom
$24K
Balyasny Asset Management
57
Balyasny Asset Management
Illinois
$23K +$4.69K +115 +17%
Man Group
58
Man Group
United Kingdom
$21K +$30.1K +738 New
Verition Fund Management
59
Verition Fund Management
Connecticut
$17K
Two Sigma Investments
60
Two Sigma Investments
New York
$17K +$23.8K +584 New
Rockefeller Capital Management
61
Rockefeller Capital Management
New York
$16K -$449 -11 -2%
TYCC
62
Texas Yale Capital Corp
Florida
$16K
Lazard Asset Management
63
Lazard Asset Management
New York
$14K +$163 +4 +0.8%
TRCT
64
Tower Research Capital (TRC)
New York
$10K -$1.96K -48 -12%
EWM
65
Endurance Wealth Management
Rhode Island
$3K
US Bancorp
66
US Bancorp
Minnesota
$3K
Wells Fargo
67
Wells Fargo
California
$3K +$285 +7 +7%
GTAM
68
Global Trust Asset Management
Florida
$3K +$3.63K +89 New
AWM
69
Ameliora Wealth Management
Switzerland
$2K +$3.38K +83 New
FDCDDQ
70
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.13K
CA
71
Crewe Advisors
Utah
$1K
Osaic Holdings
72
Osaic Holdings
Arizona
$1K
Royal Bank of Canada
73
Royal Bank of Canada
Ontario, Canada
$1K
Federated Hermes
74
Federated Hermes
Pennsylvania
$1K +$449 +11 New
CUAMC
75
China Universal Asset Management Company
China
$1K +$1.22K +30 New

QTTB Hedge Fund Activity: Q3 2022 in Review

83 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q3 2022, worth a combined $38.4M — down 23% from $49.9M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of QTTB and 10 opened new positions — a net loss of 4 holders — while 27 trimmed existing stakes and 15 added.

The largest buyer was Renaissance Technologies, adding an estimated $295K. The largest seller was Fidelity Investments, cutting an estimated $889K.

  • 83 institutional investors held Q32 Bio (QTTB) as of Q3 2022, down from 87 in Q2 2022.
  • Funds reported $38.4M of Q32 Bio stock for Q3 2022, down 23% quarter-over-quarter.
  • 10 funds opened new Q32 Bio positions in Q3 2022 and 14 closed out, a net change of -4 holders.
  • The largest Q32 Bio buyer in Q3 2022 was Renaissance Technologies, an estimated $295K added.
  • The largest Q32 Bio seller in Q3 2022 was Fidelity Investments, an estimated $889K sold.

Based on aggregated 13F filings for Q3 2022.